Thymidylate synthase polymorphisms are associated to therapeutic outcome of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
admin-cespu
Bibliographic reference:
Lima, A., Seabra, V., Martins, S., Coelho, A., Araújo, A., Medeiros, A. (2014). Thymidylate synthase polymorphisms are associated to therapeutic outcome of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Molecular Biology Reports, 41(5):3349-3357.
Lima, A., Seabra, V., Martins, S., Coelho, A., Araújo, A., Medeiros, A. (2014). Thymidylate synthase polymorphisms are associated to therapeutic outcome of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Molecular Biology Reports, 41(5):3349-3357.